Jouet Jp

发表

Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.

A. Fischer, J. Reiffers, E. Gluckman, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

I. Yakoub-Agha, J. Jouet, V. Coiteux, 2010, Bone Marrow Transplantation.

Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation

E. Wattel, F. Bauters, X. Leleu, 1999, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.

S. Chevret, I. Yakoub-Agha, E. Wattel, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.

G. Leverger, D. Blaise, J. Reiffers, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)

A. Baruchel, H. Tilly, D. Blaise, 2000, Bone Marrow Transplantation.

Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study

M. Bernard, N. Ifrah, F. Guilhot, 2001, Leukemia.

A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy

I. Yakoub-Agha, F. Bauters, S. Depil, 2006, Leukemia.

Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.

R. Beuscart, P. Fenaux, F. Bauters, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation

J. Bourhis, D. Blaise, P. Tiberghien, 2012, Bone Marrow Transplantation.

Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

M. Labopin, J. Reiffers, O. Ringdén, 1997, Transplantation proceedings.

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, J. Reiffers, O. Ringdén, 1996, Bone marrow transplantation.

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

J. Bourhis, D. Blaise, M. Mohty, 2003, Leukemia.

Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission.

X. Troussard, V. Leblond, M. Leporrier, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD

I. Yakoub-Agha, J. Jouet, B. Catteau, 2008, Bone Marrow Transplantation.

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

M. Labopin, P. Morel, P. Fenaux, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)

E. Deconinck, X. Troussard, V. Leblond, 1997, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG.

A. Gratwohl, S. Brunet, N. Milpied, 1991, Bone marrow transplantation.

Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study

D. Blaise, C. Chabannon, D. Maraninchi, 1998, Bone Marrow Transplantation.